학술논문
A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma in vivo
Document Type
Article
Source
In iScience 17 March 2023 26(3)
Subject
Language
ISSN
2589-0042